Form D · Biotechnology
AnchorTherapeutics, Inc
Cambridge, MA · CIK 0001417010
Offering snapshot reported Aug 23, 2010 · SEC filing
- Reported sold
- $5M Offering amount: $15M
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 19, 2010 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 23, 2010 | Initial | $5,000,000 | No comparison | 4 | SEC filing |
| May 27, 2009 | Amendment | $18,999,997 | No comparison | Not reported | SEC filing |
| Oct 29, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-146793
Source: Form D, filed Aug 23, 2010. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jens Eckstein | Director |
| Jnes Eckstein | Director |
| Stephen Hunt | Executive |
| Frederick Jones | Director, Executive |
| Frederick Jones, Iii, M.D., Mba | Director, Executive |
| Robert Kamen | Director |
| Athan Kuliopulos | Director |
| Thomas Mc Murry | Executive |
| Christopher K. Mirabelli | Director |
| Lauren Silverman | Director |
| Michael Webb | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
67 Rogers Street
Cambridge, MA, 02142
Cambridge, MA, 02142